NOVO, Giuseppina
 Distribuzione geografica
Continente #
NA - Nord America 31.025
EU - Europa 19.181
AS - Asia 15.089
SA - Sud America 2.548
AF - Africa 516
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 23
Totale 68.419
Nazione #
US - Stati Uniti d'America 30.612
SG - Singapore 5.785
RU - Federazione Russa 4.955
IT - Italia 4.082
CN - Cina 3.673
BR - Brasile 2.074
DE - Germania 2.065
FI - Finlandia 2.034
HK - Hong Kong 1.626
UA - Ucraina 1.546
VN - Vietnam 1.472
PL - Polonia 1.008
FR - Francia 756
GB - Regno Unito 751
IE - Irlanda 692
JP - Giappone 510
BD - Bangladesh 359
SE - Svezia 351
IN - India 335
KR - Corea 259
NL - Olanda 197
AR - Argentina 178
CA - Canada 169
CI - Costa d'Avorio 153
RO - Romania 153
IQ - Iraq 145
BE - Belgio 140
TR - Turchia 133
MX - Messico 129
AT - Austria 107
UZ - Uzbekistan 92
ES - Italia 87
ZA - Sudafrica 86
PK - Pakistan 82
VE - Venezuela 73
IR - Iran 72
CH - Svizzera 66
ID - Indonesia 66
MY - Malesia 59
MA - Marocco 58
EC - Ecuador 55
EG - Egitto 51
PH - Filippine 48
KE - Kenya 45
CL - Cile 39
SA - Arabia Saudita 39
NP - Nepal 38
CO - Colombia 35
AE - Emirati Arabi Uniti 34
AZ - Azerbaigian 34
TN - Tunisia 31
AU - Australia 30
CZ - Repubblica Ceca 29
DZ - Algeria 29
PY - Paraguay 28
JO - Giordania 25
UY - Uruguay 25
JM - Giamaica 24
TW - Taiwan 22
AL - Albania 21
BO - Bolivia 21
KZ - Kazakistan 21
GR - Grecia 20
IL - Israele 20
LB - Libano 20
TH - Thailandia 19
LT - Lituania 18
PE - Perù 18
PA - Panama 17
BG - Bulgaria 15
EU - Europa 14
OM - Oman 14
BY - Bielorussia 13
CR - Costa Rica 13
HN - Honduras 12
KG - Kirghizistan 12
PS - Palestinian Territory 11
SY - Repubblica araba siriana 11
DO - Repubblica Dominicana 9
HR - Croazia 9
HU - Ungheria 9
QA - Qatar 9
CU - Cuba 8
GE - Georgia 8
NG - Nigeria 8
PT - Portogallo 8
RS - Serbia 8
SN - Senegal 8
BH - Bahrain 7
CG - Congo 7
ET - Etiopia 7
TT - Trinidad e Tobago 7
DK - Danimarca 6
KW - Kuwait 6
MD - Moldavia 6
NZ - Nuova Zelanda 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
AO - Angola 5
GT - Guatemala 5
Totale 68.317
Città #
Ashburn 4.133
Singapore 3.802
Fairfield 2.733
Chandler 2.280
San Jose 1.737
Woodbridge 1.700
Hong Kong 1.579
Houston 1.378
Wilmington 1.289
Ann Arbor 1.199
Seattle 1.101
Cambridge 952
Zgierz 898
Jacksonville 808
Moscow 786
Dublin 675
Beijing 646
Medford 621
Des Moines 606
Palermo 523
Los Angeles 494
Tokyo 491
Ho Chi Minh City 488
New York 474
Santa Clara 470
Frankfurt am Main 393
Princeton 387
Lauterbourg 386
Council Bluffs 377
Nanjing 367
Hanoi 365
Altamura 357
Dallas 341
Lawrence 268
The Dalles 243
Dearborn 240
Helsinki 229
Hefei 218
Tulsa 218
Milan 213
Boardman 209
San Diego 200
Buffalo 194
Rome 166
Munich 159
Abidjan 152
Chicago 151
São Paulo 148
Nanchang 134
Brussels 131
Krefeld 130
Shenyang 124
Venice 121
Orem 120
London 116
Ludwigshafen am Rhein 112
Jinan 108
Changsha 101
Hebei 98
Tianjin 98
Amsterdam 92
Atlanta 84
Columbus 84
Jiaxing 79
Nuremberg 78
Da Nang 77
Bremen 74
Tashkent 71
Kumar 68
Chennai 65
San Mateo 65
San Paolo di Civitate 65
Belo Horizonte 61
Guangzhou 61
Lappeenranta 60
Rio de Janeiro 60
Haiphong 59
Naples 59
Warsaw 58
Denver 57
Phoenix 57
Zhengzhou 53
Montreal 52
Düsseldorf 51
Tehran 50
Baghdad 48
Johannesburg 48
Seongnam 48
Toronto 48
Verona 48
Vienna 48
Brooklyn 47
Ningbo 47
City of London 46
Stockholm 46
Brasília 43
Shanghai 43
Florence 41
Nairobi 40
Falls Church 39
Totale 41.557
Nome #
L'ecocardiografia speckle tracking: Roadmap per la misurazione e l'utilizzo clinico 867
Effects of SGLT2 inhibitors on cardiac structure and function 512
Acidi grassi ematici e infarto miocardico 482
ATRIAL FIBRILLATION AND MILD COGNITIVE IMPAIRMENT: WHAT CORRELATION? 309
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors 301
Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes. 280
Chronic pharmacological treatment in takotsubo cardiomyopathy 278
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity 275
Anticoagulant drugs in noncompaction: a mandatory therapy? 270
Impact of insulin resistance on cardiac and vascular function 269
[Cardiovascular risk profile of patients with psoriasis]. 263
G-protein-coupled receptor kinase 5 polymorphism and Takotsubo cardiomyopathy. 263
Asymptomatic carotid lesions add to cardiovascular risk prediction 261
Early detection of coronary artery flow and myocardial perfusion impairment in hypertensive patients evidenced by myocardial blush grade (MBG) and thrombolysis in myocardial infarction (TIMI) frame count (TFC). 256
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 253
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors 252
A rare case of Prinzmetal angina 3 days after coronary artery stenting with a second-generation drug-eluting stent. 251
Integrated non-invasive approach to atherosclerosis with cardiac CT and carotid ultrasound in patients with suspected coronary artery disease 251
Pharmacological therapy in children with atrial fibrillation and atrial flutter 249
Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction 247
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 245
Management of direct oral anticoagulants in patients with atrial fibrillation undergoing cardioversion 241
Approccio diagnostico non invasivo con tomografia computerizzata multidetettore a 40 strati per lo studio della malattia aterosclerotica coronarica 240
Asymptomatic carotid lesions and aging: role of hypertension and other traditional and emerging risk factors 239
A cardiac fibroma in a 7 year-old asymptomatic girl admitted for ECG anomalies 237
Chemotherapy-induced cardiotoxicity: role of the conventional echocardiography and the Tissue Doppler 233
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 233
Angioplastica percutanea e stent nel trattamento delle lesioni steno-obliteranti della succlavia sinistra in sogetti conm furto coronarop e vertebro-succlaveare. 231
Assessment of no-reflow phenomenon by myocardial blush grade and pulsed wave tissue doppler imaging in patients with acute coronary syndrome 230
INFLUENCE OF CAROTID AND PERIPHERAL ATHEROSCLEROSIS ON THE OUTCOME OF PATIENTS WITH ACUTE CORONARY SYNDROME 229
Long-term parameters of heart rate variability in patients with insulin-resistance 229
Association between asymptomatic carotid atherosclerosis and degenerative aortic stenosis. 228
Changes of arterial hemodynamics in patients with type 2 diabetes mellitus or impaired glucose tolerance 227
Diagnosis and definition of biventricular non-compaction associated to Ebstein's anomaly 227
Angiographic Evaluation of Coronary Microvascular Dysfunction in Patients with Heart Failure and Preserved Ejection Fraction 227
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION OR TYPE-II DIABETES 227
Magnetic resonance in isolated noncompaction of the ventricular myocardium 226
Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience 226
Usefulness of regional right ventricular and right atrial strain for prediction of early and late right ventricular failure following a left ventricular assist device implant: A machine learning approach 226
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 225
Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapy. 224
The percutaneous treatment of Patent Foramen Ovale, an effective and safe therapeutic choice 223
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis 221
Risk factors for contrast induced nephropathy: a study among Italian patients. 221
Left ventricular noncompaction presenting like a doublechambered left ventricle 220
Characteristics of coronary microcirculatory function in patients with Takotsubo syndrome 219
Percutaneous angioplasty and stenting of left subclavian artery lesions for the treatment of patients with concomitant vertebral and coronary subclavian steal syndrome. 216
Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights From the International, Multicenter GEIST Registry 216
Fetuin-A is Associated to Serum Calcium and AHSG T256S Genotype but Not to Coronary Artery Calcification 215
Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction 215
Native Mitral Valve Endocarditis Caused by Neisseria elongata subsp. nitroreducens in a Patient with Marfan Syndrome: First Case in Italy and Review of the Literature 215
Isolated left ventricular non-compaction: A larger part of submerged iceberg with criteria for diagnosis to the limits of standard 214
Chemotherapy-induced cardiotoxicity: role of the tissue Doppler in the early diagnosis of left ventricular dysfunction. 212
Remodeled ostial atherosclerotic plaque in a single coronary artery demonstrated by computed tomography coronary angiography 212
Climatic variables in Takotsubo cardiomyopathy: role of temperature 211
Chronic inflammation: A key role in degeneration of bicuspid aortic valve 211
CARDIOVASCULAR MAGNETIC RESONANCE IN CHILDREN WITH IDIOPATHIC MONOMORPHIC VENTRICULAR TACHYCARDIA OR COMPLEX VENTRICULAR EXTRASYSTOLES 210
The association between coronary microvascular dysfunction and carotid intima media thickness in patients with cardiac syndrome X 210
Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized. 210
ACCURATEZZA DIAGNOSTICA DELLA TC 40 STRATI IN PAZIENTI CON DOLORE TORACICO 209
Atherosclerosis, inflammation and Chlamydia pneumoniae. 209
DELAYED MRI HYPERENHANCEMENT IN NONCOMPACTION: SIGN OF FIBROSIS CORRELATED WITH CLINICAL SEVERITY 209
IN-HOSPITAL COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION IN HYPERTENSIVE SUBJECTS 208
Anticoagulant drugs in noncompaction: a mandatory therapy? 208
An uncommon case of syncope in a 4-year-old child affected by a long QT syndrome 207
Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up 207
Bicuspid aortic valve and unruptured sinus of Valsalva aneurysm, a rare association 207
Alteration of Heart Rate Variability as an Early Predictor of Cardiovascular Events: A Look at Current Evidence 205
Infective Endocarditis: Preliminary Results of a Cohort Study in the Southern Italian Population 205
Relationship between endothelial dysfunction, intima media thickness, hypertension and other cardiovascular risk factors in asymptomatic subjects 204
Post-myocarditis autonomic imbalance: A possible cause of arrhythmias? 204
Chronic stress and early recurrence of takotsubo cardiomyopathy: A clinical case 204
BIOMARKERS OF CORONARY MICROVASCULAR DYSFUNCTION IN PATIENTS WITH MICROVASCULAR ANGINA: A NARRATIVE REVIEW 204
IDIOPHATIC MONOMORPHIC VENTRICULAR TACHYCARDIA AND SYMPATHETIC IMBALANCE 203
Early subclinical ventricular dysfunction in patients with insulin resistance 203
Erectile dysfunction is associated with low total serum testosterone levels and impaired flow-mediated vasodilation in intermediate risk men according to the framingham risk score 203
Chest pain due to late huge coronary pseudoaneurysm following stent implantation 203
Fatal heart failure induced by pazopanib in a sarcoma patient previously treated with gemcitabine 203
Preclinical carotid atherosclerosis enhances the global cardiovascular risk and increases the rate of cerebro- and cardiovascular events in a five-year follow-up 201
Atherosclerosis, degenerative aortic stenosis and statins 200
A risk score derived from the analysis of a cluster of 27 serum inflammatory cytokines to predict long term outcome in patients with acute myocardial infarction: A pilot study 200
Scrotal swelling in a patient with paroxysmal supraventricular tachycardia 199
Transient mid-ventricular dyskinesia: a variant of Takotsubo syndrome 198
Selective pacing sites 198
Relationship between epicardial fat and diastolic dysfunction in obese subjects: an echocardiographic study 197
DIAGNOSTIC ACCURACY OF MDCT 40 SLICES IN PATIENTS WITH CHEST PAIN 196
Aterosclerosi Preclinica e Rischio Cardiovascolare Globale 196
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction 196
Helicobacter pylori and atrial fibrillation: absence of correlations 195
Evaluation of diastolic function by the Tissue doppler in children affected by non- compaction 194
Influence of climatic variables on acute myocardial infarction hospital admissions 194
Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study 194
A possible easy way to predict response to cardiac resynchronization therapy: The role of QRS Index 193
Neuromuscular disorders and non compaction: How much is the strength of the association and how can it be suspected? 193
The long QT syndrome in pediatric age: prognosis and risk factor 193
Prognostic role of aldosterone in patients with acute coronary syndrome: short and medium term follow-up. 193
Chemotherapy cardiotoxicity: cardioprotective drugs and early identification of cardiac dysfunction. 193
Impact of preclinical carotid atherosclerosis on global cardiovascular risk stratification and events in a 10-year follow-up: comparison between the algorithms of the Framingham Heart Study, the European SCORE and the Italian 'Progetto Cuore' 193
Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention 191
Troponin I/ejection fraction ratio: A new index to differentiate Takotsubo cardiomyopathy from myocardial infarction 190
Totale 23.312
Categoria #
all - tutte 232.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 232.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021917 0 0 0 0 0 0 0 0 0 0 453 464
2021/20224.212 191 806 88 193 123 179 184 265 506 610 226 841
2022/20237.199 623 1.197 106 731 681 985 626 1.034 747 67 272 130
2023/20243.277 137 380 194 403 234 607 361 410 39 78 134 300
2024/20258.350 244 562 644 702 336 298 738 514 593 847 1.114 1.758
2025/202626.222 1.865 797 1.544 2.008 2.825 4.037 3.836 2.972 2.087 3.162 1.089 0
Totale 70.539